Clustering data with hclust algorithm for (Study ST003256)

(Analysis AN005338)
MetaboliteStructureF1F2F3F4F5F6F7F8F9F10F11F12F13F14F15F16F17F18
PC 16:0/20:4;O3ME8565780.000.000.000.000.000.000.180.500.640.490.151.612.672.490.211.133.433.17
PC 18:0/22:4;OME8565850.000.000.000.000.000.001.031.622.201.660.871.521.641.380.940.851.851.16
PC 18:1/20:4;OME8565820.000.000.000.000.000.000.960.821.101.100.721.522.792.250.900.792.612.32
PC 16:0/22:4;OME8565840.000.000.000.000.000.000.781.151.260.860.881.152.281.741.390.992.521.73
PC 16:0/20:4;OME8565760.000.000.000.000.000.001.180.861.411.320.801.402.501.831.120.782.641.99
PC 18:0/20:4;OME8565790.000.000.000.000.000.001.230.781.201.181.161.352.291.881.390.842.651.92
PC 18:0/20:4;O3ME8565810.000.000.00NA0.000.000.190.520.740.660.641.653.582.180.301.302.701.04
PC 18:0/20:4;O2ME8565800.000.000.000.000.000.000.540.961.471.140.892.402.521.650.991.101.961.26
PC 16:0/20:4;O2ME8565770.000.000.000.000.000.000.300.701.141.030.502.613.242.130.811.052.281.44
PC 18:1/20:4;O2ME8565830.000.000.000.000.000.000.270.711.110.800.482.513.172.050.701.092.601.45
PI 18:1/20:4;O2ME8565931.221.241.670.070.300.59NA0.87NANANA0.85NANANA1.59NANA
PI 18:0/20:4;O3ME8565910.512.422.350.020.040.03NA0.36NANANA1.84NANANA1.43NANA
PI 18:0/22:4;O3*ME8565980.582.222.130.030.020.03NA0.36NANANA1.98NANANA1.66NANA
PI 18:0/20:4;O2ME8565901.022.182.130.060.100.08NA0.57NANANA1.66NANANA1.20NANA
PI 18:0/22:4;O2*ME8565970.602.152.130.100.120.05NA0.58NANANA1.73NANANA1.23NANA
PI 18:1/20:4;O3ME8565940.722.332.290.040.130.06NA0.52NANANA1.61NANANA0.99NANA
PI 18:0/22:4;OME8565961.121.901.790.150.140.11NA0.73NANANA1.58NANANA1.47NANA
PI 18:0/20:4;OME8565890.891.902.220.120.140.14NA0.66NANANA1.59NANANA1.34NANA
PI 18:1/20:4;OME8565920.841.921.960.310.240.25NA0.63NANANA1.56NANANA1.29NANA
PI 16:0/20:4;OME8565861.021.991.600.410.560.59NA0.29NANANA1.53NANANA1.01NANA
PI 16:0/20:4;O3ME8565880.961.301.460.770.290.38NA0.48NANANA1.45NANANA1.34NANA
PE 18:1/20:4;O3ME8565690.392.141.980.040.130.080.190.240.190.140.082.152.141.430.451.842.711.50
PE 16:0/22:4;O3*ME8565720.432.693.050.060.160.110.150.170.330.200.071.701.611.080.411.272.271.27
PE 18:0/22:4;O3*ME8565750.642.872.680.070.120.100.170.310.180.150.161.851.721.330.271.782.161.52
PE 16:0/20:4;O3ME8565630.462.712.920.060.200.150.180.220.180.170.152.131.670.910.332.022.141.10
PE 18:0/20:4;O3ME8565660.502.462.640.050.080.080.180.330.180.160.122.011.781.020.332.112.291.23
PE 16:0/22:4;OME8565701.601.963.170.380.650.540.250.590.480.330.172.050.920.430.291.921.010.47
PE 18:0/22:4;O2*ME8565740.852.232.600.050.120.070.350.650.370.310.302.001.480.810.391.811.840.98
PE 18:1/20:4;O2ME8565681.362.212.850.050.060.040.460.640.430.560.431.901.210.710.521.701.430.81
PE 18:0/22:4;OME8565731.571.441.610.640.610.621.691.141.141.230.350.950.750.540.521.000.920.63
PE 16:0/20:4;O2ME8565621.142.021.730.310.310.160.410.780.970.380.421.401.190.500.362.101.830.85
PE 18:1/20:4;OME8565670.601.451.630.210.330.270.480.680.710.690.531.751.691.140.711.581.821.28
PE 18:0/20:4;O2ME8565650.871.361.630.240.330.260.980.830.970.980.751.361.400.970.711.281.601.13
PE 16:0/20:4;OME8565611.131.671.850.390.460.400.560.780.780.940.511.371.231.070.671.371.491.23
PE 18:0/20:4;OME8565641.291.821.980.350.370.370.740.800.660.650.421.411.280.940.641.391.531.08

Factors:

F1Sample source:Breast cancer cells | Genotype:shCtrl | Treatment:DMSO | Treatment Time:2 h
F2Sample source:Breast cancer cells | Genotype:shCtrl | Treatment:RSL3 (10 µM) | Treatment Time:2 h
F3Sample source:Breast cancer cells | Genotype:shCtrl | Treatment:RSL3 (1 µM) | Treatment Time:2 h
F4Sample source:Breast cancer cells | Genotype:shZeb1 | Treatment:DMSO | Treatment Time:2 h
F5Sample source:Breast cancer cells | Genotype:shZeb1 | Treatment:RSL3 (10 µM) | Treatment Time:2 h
F6Sample source:Breast cancer cells | Genotype:shZeb1 | Treatment:RSL3 (1 µM) | Treatment Time:2 h
F7Sample source:Breast cancer cells | Genotype:WT | Treatment:DMSO | Treatment Time:24 h
F8Sample source:Breast cancer cells | Genotype:WT | Treatment:DMSO | Treatment Time:2 h
F9Sample source:Breast cancer cells | Genotype:WT | Treatment:DMSO | Treatment Time:4 h
F10Sample source:Breast cancer cells | Genotype:WT | Treatment:DMSO | Treatment Time:6 h
F11Sample source:Breast cancer cells | Genotype:WT | Treatment:RSL3 (10 µM) | Treatment Time:24 h
F12Sample source:Breast cancer cells | Genotype:WT | Treatment:RSL3 (10 µM) | Treatment Time:2 h
F13Sample source:Breast cancer cells | Genotype:WT | Treatment:RSL3 (10 µM) | Treatment Time:4 h
F14Sample source:Breast cancer cells | Genotype:WT | Treatment:RSL3 (10 µM) | Treatment Time:6 h
F15Sample source:Breast cancer cells | Genotype:WT | Treatment:RSL3 (1 µM) | Treatment Time:24 h
F16Sample source:Breast cancer cells | Genotype:WT | Treatment:RSL3 (1 µM) | Treatment Time:2 h
F17Sample source:Breast cancer cells | Genotype:WT | Treatment:RSL3 (1 µM) | Treatment Time:4 h
F18Sample source:Breast cancer cells | Genotype:WT | Treatment:RSL3 (1 µM) | Treatment Time:6 h
Data matrix
  logo